Blue Cell Therapeutics ApS: Financial statements 2025
CVR: 39981610
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Blue Cell Therapeutics ApS (CVR 39981610) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,780,568 and a net result of DKK -21,221,120 compared with DKK -15,189,850 the year before. Equity in the 2025 report amounted to DKK -8,126,690. The company had 9 employees in the financial year.
- Gross Profit
- DKK -5,780,568
- Profit/Loss
- DKK -21,221,120
- Equity
- DKK -8,126,690
- Total Assets
- DKK 4,823,922
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -5.8M | -21.2M | -8.1M | 9 |
| 2024 | - | -3.1M | -15.2M | 13.1M | 12 |
| 2023 | - | -742K | -15.3M | 8.4M | 14 |
| 2022 | - | 852K | -12.6M | 9.9M | 12 |
| 2021 | - | -844K | -14.2M | 12.5M | 7 |
Official annual report
How creditworthy is Blue Cell Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of August 8, 2025, Ole Vahlgren has joined the board of directors of Blue Cell Therapeutics ApS.
As of August 8, 2025, Olav Hellebø has joined the board of directors of Blue Cell Therapeutics ApS.
As of August 8, 2025, Anders Vadsholt has left the board of directors of Blue Cell Therapeutics ApS.
As of August 7, 2025, Ole Vahlgren has left the board of directors of Blue Cell Therapeutics ApS.
Blue Cell Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -3,052,648, and the net result was DKK -15,189,850.
About Blue Cell Therapeutics ApS
Blue Cell Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Regenerative Therapeutics IVS. The management consists of Søren Paludan Sheikh. The board consists of Olav Hellebø (chair), Anella Rogaczewski, Michael Ulveman and Ole Vahlgren. The company is owned by ANDRÉ ROGACZEWSKI HOLDING II ApS and SPSheikh Holding ApS. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -5,780,568 and a net result of DKK -21,221,120 compared with DKK -15,189,850 the year before. Equity in the 2025 report amounted to DKK -8,126,690.